Daiwa Securities Group Inc. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$01020.0%0.00%
Q2 2021$01020.0%0.00%
Q1 2021$0
-100.0%
1020.0%0.00%
Q4 2020$1,0000.0%102
-40.0%
0.00%
Q3 2020$1,0001700.0%0.00%
Q2 2020$01700.0%0.00%
Q1 2020$0
-100.0%
1700.0%0.00%
Q4 2019$1,000
-50.0%
1700.0%0.00%
Q3 2019$2,0000.0%1700.0%0.00%
Q2 2019$2,0000.0%1700.0%0.00%
Q1 2019$2,000
-60.0%
170
-43.3%
0.00%
Q4 2018$5,0003000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders